Referral Art. 30, EMEA/H/A-30/1375 regarding Nasonex and associated names was finalised 20 January 2015.
Referral Art. 31, EMEA/H/A-31/1383 regarding Colistimethate Alvogen 1 milljón a.e. og 2 milljónir a.e. stungulyfs-/innrennslisstofn, lausn was finalised 17 December 2014.
Referral Art. 107i, EMEA/H/C/PSUSA/1152/201311 regarding Docetaxel (with alcohol in formulation) was finalised 23 December 2014.
- Information to the Marketing Authorisation Holder – Oxynal-Targin and associated names
- Information to the Marketing Authorisation Holder – Plendil and associated names
- The IMA over Christmas and New Year